[1] |
中华医学会皮肤性病学分会药物不良反应研究中心. Stevens⁃Johnson综合征/中毒性表皮坏死松解症诊疗专家共识[J]. 中华皮肤科杂志, 2021,54(5):376⁃381. doi: 10.35541/cjd.2020 1177.
|
[2] |
Lee HY, Walsh SA, Creamer D. Long⁃term complications of Stevens⁃Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow⁃up[J]. Br J Dermatol, 2017,177(4):924⁃935. doi: 10.1111/bjd.15 360.
|
[3] |
Aihara M, Kano Y, Fujita H, et al. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. J Dermatol, 2015,42(8):768⁃777. doi: 10.1111/1346⁃8138.12925.
|
[4] |
韩锋, 张静静, 侯彦丽, 等. 单纯单次血浆置换疗法治疗17例中毒性表皮坏死松解症临床观察[J]. 中华皮肤科杂志, 2018,51(12):896⁃898. doi: 10.3760/cma.j.issn.0412⁃4030.2018.12.010.
|
[5] |
Yin B, Vinturache A, Zhang Y, et al. Toxic epidermal necrolysis in a child[J]. J Allergy Clin Immunol Pract, 2020,8(5):1712⁃1713. doi: 10.1016/j.jaip.2020.01.018.
|
[6] |
McPherson T, Exton LS, Biswas S, et al. British Association of Dermatologists′ guidelines for the management of Stevens⁃Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018[J]. Br J Dermatol, 2019,181(1):37⁃54. doi: 10.1111/bjd.17841.
|
[7] |
Shi T, Chen H, Huang L, et al. Fatal pediatric Stevens⁃Johnson syndrome/toxic epidermal necrolysis: three case reports[J]. Medicine (Baltimore), 2020,99(12):e19431. doi: 10.1097/MD. 0000000000019431.
|
[8] |
Techasatian L, Panombualert S, Uppala R, et al. Drug⁃induced Stevens⁃Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital[J]. World J Pediatr, 2017,13(3):255⁃260. doi: 10.1007/s12519⁃016⁃0057⁃3.
|
[9] |
Tocco⁃Tussardi I, Huss F, Presman B. Microbiological findings and antibacterial therapy in Stevens⁃Johnson syndrome/toxic epidermal necrolysis patients from a Swedish burn center[J]. J Cutan Pathol, 2017,44(5):420⁃432. doi: 10.1111/cup.12894.
|
[10] |
Schneider JA, Cohen PR. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures[J]. Adv Ther, 2017,34(6):1235⁃1244. doi: 10.1007/s12325⁃017⁃0530⁃y.
|
[11] |
Lee HY. Wound management strategies in Stevens⁃Johnson syndrome/toxic epidermal necrolysis: an unmet need[J]. J Am Acad Dermatol, 2018,79(4):e87⁃e88. doi: 10.1016/j.jaad.2018. 05.1258.
|
[12] |
Rogers AD, Blackport E, Cartotto R. The use of Biobrane® for wound coverage in Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Burns, 2017,43(7):1464⁃1472. doi: 10. 1016/j.burns.2017.03.016.
|
[13] |
Houschyar KS, Tapking C, Borrelli MR, et al. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a 10⁃year experience in a burns unit[J]. J Wound Care, 2021,30(6):492⁃496. doi: 10.12968/jowc.2021.30.6.492.
|
[14] |
Chatproedprai S, Wutticharoenwong V, Tempark T, et al. Clinical features and treatment outcomes among children with Stevens⁃Johnson syndrome and toxic epidermal necrolysis: a 20⁃year study in a tertiary referral hospital[J]. Dermatol Res Pract, 2018,2018:3061084. doi: 10.1155/2018/3061084.
|
[15] |
Duong TA, de Prost N, Ingen⁃Housz⁃Oro S, et al. Stevens⁃Johnson syndrome and toxic epidermal necrolysis: follow⁃up of pulmonary function after remission[J]. Br J Dermatol, 2015,172(2):400⁃405. doi: 10.1111/bjd.13505.
|